Nuveen Asset Management, LLC Volitionrx LTD Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.01 - $3.78 $505,303 - $634,567
-167,875 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$3.33 - $6.5 $26,986 - $52,676
8,104 Added 5.07%
167,875 $634,000
Q4 2020

Feb 16, 2021
BUY
$2.88 - $4.33 $104,005 - $156,369
36,113 Added 29.2%
159,771 $622,000
Q3 2020

Nov 16, 2020
SELL
$2.94 - $4.05 $41,218 - $56,781
-14,020 Reduced 10.18%
123,658 $397,000
Q2 2020

Aug 14, 2020
BUY
$2.89 - $4.32 $397,889 - $594,768
137,678 New
137,678 $535,000

Others Institutions Holding VNRX

# of Institutions
26
Shares Held
17.8M
Call Options Held
41K
Put Options Held
100
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $33.8M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email